Portland-based ImmuCell reports big revenue boost for 3rd quarter

Portland biotech firm ImmuCell Corp. on Monday reported a significant revenue increase for the third quarter, with sales up 38 percent from a year earlier to $3 million.

The company, which develops and manufactures bovine health products for the dairy and beef industries, said the revenue boost was the result of eliminating a production bottleneck that had restricted sales in 2018 despite increased customer demand.

ImmuCell reported a net loss of $503,000, or 7 cents per share, for the third quarter as it continued to absorb the costs of a $20 million manufacturing facility completed in late 2017 for a new product called Re-Tain that must receive regulatory approval before sales can commence. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024